Answer
The risk of renal dysfunction may increase when zoledronic acid concentrate is combined with thalidomide in patients with multiple myeloma.
Sources for this answer
- Zoledronic Acid 4 mg/5 ml Concentrate for solution for InfusionMorningside Healthcare Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 1Document updated
Sources checked